Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Remitting seronegative symmetrical synovitis with pitting oedema: disease or syndrome?</title><author><name sortKey="Schaeverbeke, T" sort="Schaeverbeke, T" uniqKey="Schaeverbeke T" first="T" last="Schaeverbeke">T. Schaeverbeke</name></author><author><name sortKey="Fatout, E" sort="Fatout, E" uniqKey="Fatout E" first="E" last="Fatout">E. Fatout</name></author><author><name sortKey="Marce, S" sort="Marce, S" uniqKey="Marce S" first="S" last="Marcé">S. Marcé</name></author><author><name sortKey="Vernhes, J P" sort="Vernhes, J P" uniqKey="Vernhes J" first="J P" last="Vernhes">J P Vernhes</name></author><author><name sortKey="Halle, O" sort="Halle, O" uniqKey="Halle O" first="O" last="Hallé">O. Hallé</name></author><author><name sortKey="Antoine, J F" sort="Antoine, J F" uniqKey="Antoine J" first="J F" last="Antoine">J F Antoine</name></author><author><name sortKey="Lequen, L" sort="Lequen, L" uniqKey="Lequen L" first="L" last="Lequen">L. Lequen</name></author><author><name sortKey="Bannwarth, B" sort="Bannwarth, B" uniqKey="Bannwarth B" first="B" last="Bannwarth">B. Bannwarth</name></author><author><name sortKey="Dehais, J" sort="Dehais, J" uniqKey="Dehais J" first="J" last="Dehais">J. Dehais</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">7677447</idno><idno type="pmc">1009968</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1009968</idno><idno type="RBID">PMC:1009968</idno><date when="1995">1995</date><idno type="wicri:Area/Pmc/Corpus">001341</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001341</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Remitting seronegative symmetrical synovitis with pitting oedema: disease or syndrome?</title><author><name sortKey="Schaeverbeke, T" sort="Schaeverbeke, T" uniqKey="Schaeverbeke T" first="T" last="Schaeverbeke">T. Schaeverbeke</name></author><author><name sortKey="Fatout, E" sort="Fatout, E" uniqKey="Fatout E" first="E" last="Fatout">E. Fatout</name></author><author><name sortKey="Marce, S" sort="Marce, S" uniqKey="Marce S" first="S" last="Marcé">S. Marcé</name></author><author><name sortKey="Vernhes, J P" sort="Vernhes, J P" uniqKey="Vernhes J" first="J P" last="Vernhes">J P Vernhes</name></author><author><name sortKey="Halle, O" sort="Halle, O" uniqKey="Halle O" first="O" last="Hallé">O. Hallé</name></author><author><name sortKey="Antoine, J F" sort="Antoine, J F" uniqKey="Antoine J" first="J F" last="Antoine">J F Antoine</name></author><author><name sortKey="Lequen, L" sort="Lequen, L" uniqKey="Lequen L" first="L" last="Lequen">L. Lequen</name></author><author><name sortKey="Bannwarth, B" sort="Bannwarth, B" uniqKey="Bannwarth B" first="B" last="Bannwarth">B. Bannwarth</name></author><author><name sortKey="Dehais, J" sort="Dehais, J" uniqKey="Dehais J" first="J" last="Dehais">J. Dehais</name></author></analytic><series><title level="j">Annals of the Rheumatic Diseases</title><idno type="ISSN">0003-4967</idno><idno type="eISSN">1468-2060</idno><imprint><date when="1995">1995</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>OBJECTIVE--To evaluate the outcome of patients with remitting seronegative symmetrical synovitis with pitting oedema (RS3PE). METHODS--In a retrospective chart review study, we identified all the patients presenting with polyarthritis and pitting oedema in the past 20 years. We tried to recall the 24 patients with characteristics of RS3PE according to McCarty et al. Two patients had died and four could not be traced. Five could not be seen after the initial period of follow up; relevant data were obtained from their practitioner. For the remaining 13 patients, clinical, radiological, and biological evaluation was performed in our department, with the last assessment in 1993. RESULTS--The follow up period was from one to 18 years (mean 4.6 (SD 4.5) years). Eleven patients developed one or several recurrences of articular manifestations consisting of mild oligoarthritis (n = 8), definite spondyloarthropathy (n = 2), and rheumatoid arthritis (n = 1). The delay of the first recurrence was 18 months to 12 years after the first attack. Thirteen patients had no recurrence, but three of them developed remarkable features: rheumatoid factor, antinuclear antibodies (1/2000), Sjögren's syndrome. HLA B typing was performed in nine patients and revealed B7 (n = 2), B27 (n = 2) and B22 (n = 2). Isolated HLA B27 typing was performed in two other patients and was positive in one. CONCLUSION--The long term outcome of RS3PE can lead to different rheumatic diseases. RS3PE appears to be a syndrome related to the elderly onset of the rheumatic diseases, including spondyloarthropathy and rheumatoid arthritis, rather than a specific entity.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Rheum Dis</journal-id><journal-title>Annals of the Rheumatic Diseases</journal-title><issn pub-type="ppub">0003-4967</issn><issn pub-type="epub">1468-2060</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7677447</article-id><article-id pub-id-type="pmc">1009968</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Remitting seronegative symmetrical synovitis with pitting oedema: disease or syndrome?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Schaeverbeke</surname><given-names>T</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fatout</surname><given-names>E</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marcé</surname><given-names>S</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vernhes</surname><given-names>J P</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hallé</surname><given-names>O</given-names></name></contrib><contrib contrib-type="author"><name><surname>Antoine</surname><given-names>J F</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lequen</surname><given-names>L</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bannwarth</surname><given-names>B</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dehais</surname><given-names>J</given-names></name></contrib></contrib-group><aff>Department of Rheumatology, University Hospital of Bordeaux, University of Bordeaux II, France.</aff><pub-date pub-type="ppub"><month>8</month><year>1995</year></pub-date><volume>54</volume><issue>8</issue><fpage>681</fpage><lpage>684</lpage><abstract><p>OBJECTIVE--To evaluate the outcome of patients with remitting seronegative symmetrical synovitis with pitting oedema (RS3PE). METHODS--In a retrospective chart review study, we identified all the patients presenting with polyarthritis and pitting oedema in the past 20 years. We tried to recall the 24 patients with characteristics of RS3PE according to McCarty et al. Two patients had died and four could not be traced. Five could not be seen after the initial period of follow up; relevant data were obtained from their practitioner. For the remaining 13 patients, clinical, radiological, and biological evaluation was performed in our department, with the last assessment in 1993. RESULTS--The follow up period was from one to 18 years (mean 4.6 (SD 4.5) years). Eleven patients developed one or several recurrences of articular manifestations consisting of mild oligoarthritis (n = 8), definite spondyloarthropathy (n = 2), and rheumatoid arthritis (n = 1). The delay of the first recurrence was 18 months to 12 years after the first attack. Thirteen patients had no recurrence, but three of them developed remarkable features: rheumatoid factor, antinuclear antibodies (1/2000), Sjögren's syndrome. HLA B typing was performed in nine patients and revealed B7 (n = 2), B27 (n = 2) and B22 (n = 2). Isolated HLA B27 typing was performed in two other patients and was positive in one. CONCLUSION--The long term outcome of RS3PE can lead to different rheumatic diseases. RS3PE appears to be a syndrome related to the elderly onset of the rheumatic diseases, including spondyloarthropathy and rheumatoid arthritis, rather than a specific entity.</p></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001341 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001341 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.31. |  |